Related Experiment Videos
[Recombinant proteins containing oxytocin oligomeric sequences]
Bioorganicheskaia Khimiia
|January 1, 1996
Summary
Researchers engineered three recombinant proteins (ILOX3, ILOX6, and ILOX9) with varying oxytocinoyl-Lys fragments. Expression in E. coli resulted in heterogeneous protein products, suggesting specific proteolysis for ILOX6 and ILOX9.
Area of Science:
- Biochemistry
- Molecular Biology
- Recombinant Protein Expression
Context:
- Investigating the expression and characteristics of novel recombinant proteins.
- Utilizing E. coli as a host system for protein production.
- Focusing on proteins with C-terminal fragments of oxytocinoyl-Lys (trimer, hexamer, nonamer).
Purpose:
- To construct and express genes encoding ILOX3, ILOX6, and ILOX9 recombinant proteins.
- To analyze the protein products obtained from E. coli expression.
- To understand the heterogeneity observed in the C-terminal regions of the expressed proteins.
Summary:
- Expression plasmids for ILOX3, ILOX6, and ILOX9, containing C-terminal fragments of oxytocinoyl-Lys (trimer, hexamer, nonamer), were successfully constructed.
- Protein expression in E. coli yielded inclusion bodies with products of similar length but heterogeneous C-terminal regions.
- The ILOX3 gene likely produced full-length translation products with C-terminal lysine, while ILOX6 and ILOX9 showed evidence of site-specific proteolysis.
Impact:
- Provides insights into the expression challenges and product heterogeneity of engineered oxytocinoyl-Lys proteins.
- Contributes to the understanding of recombinant protein production and potential post-translational modifications in E. coli.
- Lays groundwork for further studies on the functional characterization of these specific recombinant protein fragments.